PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 5 analysts with an average price target of $30.67. This is a potential upside of $5.62 (22.44%) from yesterday's end of day stock price of $25.05.

Pacira Pharmaceuticals's activity chart (see below) currently has 449 price targets and 324 ratings on display. The stock rating distribution of PCRX is 72.73% BUY and 27.27% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.65% with an average time for these price targets to be met of 263.35 days.

Highest price target for PCRX is $38, Lowest price target is $25, average price target is $30.67.

Most recent stock forecast was given by LES SULEWSKI from OPPENHEIMER on 23-Sep-2026. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Nov-2025

$32

$6.79 (26.93%)

$28

13 days ago
(23-Sep-2026)

1/9 (11.11%)

$7.37 (29.92%)

29

Hold Since 01-May-2026

$25

$-0.21 (-0.83%)

$24

2 months 1 days ago
(05-Aug-2026)

2/2 (100%)

$0.13 (0.52%)

3

Buy Since 30-Apr-2020

$33

$7.79 (30.90%)

$32

2 months 1 days ago
(05-Aug-2026)

11/32 (34.38%)

$8.13 (32.69%)

261

Buy Since 21-Mar-2017

$38

$12.79 (50.73%)

$38

3 months 5 days ago
(01-Jul-2026)

8/15 (53.33%)

$12.97 (51.82%)

518

Hold Since 26-Mar-2026

$25

$-0.24 (-0.95%)

$18

6 months 10 days ago
(26-Mar-2026)

2/6 (33.33%)

$1.69 (7.25%)

50

Show more analysts

Please expand the browser size to see the chart

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 263 days for the stock forecasts to be reached, with an average price target met ratio of 59.65%.

Which analyst most recently updated their price target on PCRX (Pacira Pharmaceuticals)?

Les Sulewski

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Les Sulewski works at OPPENHEIMER and has 2 price targets and 2 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with the highest potential upside of $62.79

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

David Amsellem with the lowest potential downside of -$13.24
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?